# clm_FC7E3BF6DC06

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 3,452,800,000 United States dollar  
valid_from: 2021-09-30  
valid_to: 2022-03-31  
published: 2021-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DA35C89878EA  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 3,452,800,000 United States dollar", as of 2021-09-30 (until 2022-03-31). Claim clm_FC7E3BF6DC06, https://asof.is/claim/clm_FC7E3BF6DC06, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2021, filed 2021-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000033/0001804220-21-000033-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-11-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,138,500,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_FC7E3BF6DC06](/claim/clm_FC7E3BF6DC06.md) | [clm_CBD2A7149F84](/claim/clm_CBD2A7149F84.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.